SMR3B: A Gene Regulating Androgens in The Submaxillary Gland (G10879)

Target Name: SMR3B

NCBI ID: G10879

SMR3B

SMR3B: A Gene Regulating Androgens in The Submaxillary Gland

The submaxillary gland (SMG) is a small tissue located in the neck, responsible for producing mucus to protect the upper respiratory tract. Androgens, such as androstenedione and androsterone, are important regulators of male sexual development and function. In humans, androgens are produced by the testes and the placenta, and they play a crucial role in the development and maintenance of male reproductive organs, including the penis and prostate gland.

SMR3B, also known as submaxillary gland androgen regulated protein 3 homolog B, is a gene that encodes a protein located in the SMG. The SMR3B gene was identified as a potential drug target for androgens in 2012, due to its expression in the SMG, which is known to be androgen-regulated.

The SMR3B gene has been shown to play a role in the regulation of androgens in the SMG. Studies have shown that SMR3B is a key regulator of androgens in the SMG, and that it functions to maintain the levels of androgens in the SMG.

One of the key functions of SMR3B is its role in the regulation of androgens in the SMG. Studies have shown that SMR3B plays a role in the negative regulation of androgens in the SMG, by binding to and activating the androgen receptor (AR) on the surface of the SMG cells. This means that when androgens bind to the AR, SMR3B is activated and transcription of the SMR3B gene is increased, leading to increased levels of SMR3B protein in the SMG.

Another function of SMR3B is its role in the regulation of androgens in the SMG in the positive sense. Studies have shown that SMR3B can bind to and activate the AR in a way that increases the level of androgens in the SMG, which can lead to the stimulation of cell proliferation and the production of mucus.

SMR3B has also been shown to play a role in the regulation of androgens in the SMG in a negative sense. Studies have shown that SMR3B can bind to and inhibit the AR, which can reduce the level of androgens in the SMG and decrease the stimulation of cell proliferation and the production of mucus.

In conclusion, SMR3B is a gene that encodes a protein located in the SMG that plays a key role in the regulation of androgens in the SMG. Studies have shown that SMR3B functions to maintain the levels of androgens in the SMG and that it can play a role in the negative and positive regulation of androgens in the SMG. As a result, SMR3B may be a potential drug target or biomarker for androgens in the SMG. Further research is needed to fully understand the role of SMR3B in the regulation of androgens in the SMG and to determine its potential as a drug target or biomarker.

Protein Name: Submaxillary Gland Androgen Regulated Protein 3B

The "SMR3B Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SMR3B comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets